Cytokine profile associated with selective removal of natural anti-αGal antibodies in a sepsis model in Gal-KO mice


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Selective depletion of natural anti-Galα1-3Galβ1-4GlcNAc (so-called anti-αGal) antibodies is achieved in α1,3-galactosyltransferase knockout (Gal-KO) mice by administration of the soluble glycoconjugate of αGal GAS914. This molecule removed up to 90% of natural circulating anti-αGal antibodies without causing unspecific production of cytokines in wild-type (CBA) and Gal-KO mice. However, the removal of anti-αGal antibodies in Gal-KO mice with GAS914 in the context of sepsis after cecal ligation and puncture (CLP) was associated with a significant increase in the production of leptin, CXLC1, CXLC13, and TIMP-1 cytokines compared to vehicle (PBS)-treated controls. Despite the current lack of understanding of the underlying mechanism, our data suggest a putative role of natural anti-αGal antibodies in the regulation of some cytokines during sepsis.

作者简介

Magdiel Cruz

Bellvitge Biomedical Research Institute (IDIBELL)

Email: rmanez@bellvitgehospital.cat
西班牙, Gran Via de l’Hospitalet 199, Hospitalet de Llobregat, 08908

Daniel Gil

Bellvitge Biomedical Research Institute (IDIBELL)

Email: rmanez@bellvitgehospital.cat
西班牙, Gran Via de l’Hospitalet 199, Hospitalet de Llobregat, 08908

Cristina Costa

Bellvitge Biomedical Research Institute (IDIBELL)

Email: rmanez@bellvitgehospital.cat
西班牙, Gran Via de l’Hospitalet 199, Hospitalet de Llobregat, 08908

Rafael Mañez

Bellvitge Biomedical Research Institute (IDIBELL); Bellvitge University Hospital

编辑信件的主要联系方式.
Email: rmanez@bellvitgehospital.cat
西班牙, Gran Via de l’Hospitalet 199, Hospitalet de Llobregat, 08908; Feixa Llarga s/n, Hospitalet de Llobregat, 08907

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pleiades Publishing, Ltd., 2017